A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

Clinical trial NCT06019481 · WITHDRAWN

Trial details

NCT number: NCT06019481
Sponsor: Regeneron Pharmaceuticals
Status: WITHDRAWN
Study type: OBSERVATIONAL

Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)Biallelic Mutations in the Gap Junction Beta 2 (GJB2) Gene Digenic Mutations in GJB2/Gap Junction Beta 6 (GJB6) Genes

Start date: 2025-06-30
Primary completion: 2030-06-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.